Keisuke Hieda

5PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersSolid tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 06, 2026
KIF23 is associated with a poor prognosis, basal subtypes and immunotherapy response in urothelial carcinoma.

|Aug 08, 2026
Impact of surgical start time on clinical outcomes in urologic surgery: a single-center study of major oncologic surgeries and adrenalectomy.

|Jul 01, 2026
Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma.

|Sep 15, 2025
Efficacy of Open-Ended Urinary Catheters in Preventing Catheter-Related Bladder Discomfort: A Randomized Controlled Trial.

Kohei Kobatake, Keisuke Goto, Tomoya Hatayama

|Oct 09, 2024
Preoperative multidisciplinary team meeting improves the incidence of positive margins in pathological T2 prostate cancer.

Kohei Kobatake, Keisuke Goto, Yukiko Honda

Pageof 1

Frequent Collaborators

5 joint publications

Kohei Kobatake

5 joint publications

Keisuke Goto

5 joint publications

Miki Naito

5 joint publications

Shunsuke Miyamoto